Article section
Seroprevalence and Associated Risk Factors of Hepatitis E Virus Infection among Pregnant Women in Akure, Ondo State, Nigeria
Abstract
Hepatitis E virus (HEV) infection, an emerging viral disease, can lead to a high rate of fulminant hepatitis, liver failure, and an increased risk of mortality for pregnant women and fetus. This study aimed at determining the prevalence of HEV infection among pregnant women attending antenatal clinic at selected Government Hospitals in Akure city, Ondo State, in order to provide a comprehensive information of the infection on this particular group of people in the city. A questionnaire was administered to the participants who indicated their consent to participate in the study to generate socio-demographical data of the participants and the level of awareness of the infection. A total of 199 blood samples was collected from the recruited apparently healthy pregnant women with no history of immunosuppressive diseases. Plasma of the collected blood was subjected to the analysis of Hepatitis E virus IgM antibody using capture and colloidal gold immunochromatographic double antibody assay and the positive samples were subjected to assessment of liver enzymes using standard assays. The study revealed a prevalence rate of 3.5% of Hepatitis E virus infection among the pregnant women in the study area. Out of the 3.5% that were positive for HEV, the highest percentage frequency of occurrence of the infection (12.50%) was found in the age group > 45 years while the least percentage frequency of occurrence of HEV infection (7.14%) was observed in age group 15-19 years. Washing of hands without soap and water after toilet use, drinking of untreated well water, and eating of left-over foods were found to be risk factors that predisposed the pregnant women to HEV infection. The high level of AST and ALT in the pregnant women is an indication of liver stress. This study showed the prevalence rate of HEV among pregnant women in Akure metropolis, the level of awareness of the infection among recruited pregnant women and factors that can predispose pregnant women to the infection. There is therefore the need for appropriate health authorities to educate the public and especially pregnant women on HEV infection and factors that can predispose them to the infection.
Keywords:
Article information
Journal
Journal of Medical Science, Biology, and Chemistry
Volume (Issue)
2(1), (2025)
Pages
1-7
Published
Copyright
Copyright (c) 2025 Oni, Omowumi Oluwarantimi, Adebolu, Tokunbo Tinuola (Author)
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Ahmed, R., & Nasheri, N. (2023). Animal reservoirs for hepatitis E virus within the Paslahepevirus genus. Veterinary Microbiology, 278, 109618. https://doi.org/10.1016/j.vetmic.2022.109618
Ajayi, B. B., Igwegbe, I., Latbone, S., Oderinde, B. S., Kida, I. M., Oyinloye, S. O., ... & Abdullahi, I. N. (2022). Seroprevalence and associated risk factors of hepatitis E virus infection among pregnant women attending Maiduguri teaching hospital, Nigeria. Microbes and Infectious Diseases, 3(1), 62-68. https://doi.org/10.21608/mid.2020.39788.1053
Denova-Gutiérrez, E., Lara-Castor, L., Hernández-Alcaraz, C., Hernández-Ávila, M., Aguilar-Salinas, C., Kershenobich, D., & Barquera, S. (2021). Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. Annals of Hepatology, 26, 100562. https://doi.org/10.1016/j.aohep.2021.100562
Ehi Airiohuodion, P., Wartel, A., Yako, A. B., & Mac, P. A. (2022). Seroprevalence and burden of hepatitis E viral infection among pregnant women in central Nigeria attending antenatal clinic at a Federal Medical Centre in Central Nigeria. Frontiers in Medicine, 9, 888218. https://doi.org/10.3389/fmed.2022.888218
Ergenç, İ., Kani, H. T., Karabacak, M., Özer, E. C., Mehdiyev, S., Jafarov, F., & Atuğ, Ö. (2023). Biologic therapy carries a very low risk of reactivation in hepatitis B surface antigen-negative phase of hepatitis B. The Turkish Journal of Gastroenterology, 34(2), 156. https://doi.org/10.5152/tjg.2022.22196
Fasakin, K. A., Aduloju, O.P., Adefisan, A. S., Olofinbiyi, B. A., Ogundare, E. O., Babatola, E. O., … & Jeremiah, Z. A. (2024). Hepatitis E virus Infection among antenatal attendees in Etiki State, Nigeria. African Journal of Laboratory Haematology and Tranfusion Science, 3(2). https://doi.org/0.59708/ajlhts.v3i2.2423
Galiana, C., Fernández-Barredo, S., García, A., Gómez, M. T., & Pérez-Gracia, M. T. (2008). Occupational exposure to hepatitis E virus (HEV) in swine workers. American Journal of Tropical Medicine and Hygiene, 78(6), 1012-1015. https://pubmed.ncbi.nlm.nih.gov/18541786
Ike, W. E., Oduleye, A. O., Ariom, T. O., Igbokwe, C. O., Ike, A. J., & Okiye, J. A. (2024a). Seroprevalence and related risk factors of Hepatitis E virus Infection among pregnant Women attendees at Adeoyo Hospital, Ibadan, Nigeria. Nigeria Journal of Biotechnology, 41(1), 212-224. https://dx.doi.org/10.4314/njb.v41i1.21
Ike, W. E., Okiye, J. A., Igbokwe, C. O., Amogechukwu J. I., Fasuyi, O. C., & Oduleye, A. O. (2024b). Seroprevalence of Hepatitis E virus Infection among pregnant Women at a Secondary Healthcare facility in Abeokuta, Nigeria. The Nigerian Journal of Pharmacy, 58(1), 76-78. https://doi.org/10.51412/psnnjp.2024.09
Junaid, S. A., Agina, S. E., & Abubakar, K. A. (2014). Epidemiology and associated risk factors of hepatitis E virus infection in Plateau State, Nigeria. Virology: research and treatment, 5. https://doi.org/10.4137/VRT.S15422
Nalunkuma, R., Nkalubo, J., & Abila, D. B. (2021). Knowledge on Infection Prevention and Control and associated factors among undergraduate health professional students at Makerere University College of Health Sciences, Uganda. PloS one, 16(8), e0255984. https://doi.org/10.1371/journal.pone.0255984
Okwara, V. C., Mbachu, I. I., Ndububa, V. I., Okpara, H. C., & Mbachu, C. P. (2021). Seroprevalence, associated factors, and fetomaternal outcome in pregnant women that tested positive to hepatitis E antibodies in Nigeria. Obstetrics and Gynecology International, 2021(1), 9341974. https://doi.org/10.1155/2021/9341974
Qian, Z., Li, T., Zhang, Y., Chen, S., Zhang, H., k Mickael, H., & Huang, F. (2023). Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China. Journal of Clinical Virology, 158, 105353. https://doi.org/10.1016/j.jcv.2022.105353
Raji, Y. E., Toung, O. P., Taib, N. M., & Sekawi, Z. B. (2022). Hepatitis E Virus: An emerging enigmatic and underestimated pathogen. Saudi journal of biological sciences, 29(1), 499-512. https://doi.org/10.1016/j.sjbs.2021.09.003
Schemmerer, M., Wenzel, J. J., Stark, K., & Faber, M. (2022). Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019. Emerging Microbes & Infections, 11(1), 1754-1763. https://doi.org/10.1080/22221751.2022.2091479
Songtanin, B., Molehin, A. J., Brittan, K., Manatsathit, W., and Nugent, K. (2023). Hepatitis E virus infections: Epidemiology, genetic diversity, and clinical considerations. Viruses, 15(6), 1389. https://doi.org/10.3390/v15061389